Multimodality treatment in immunocompromised patients with severe COVID-19: the role of IL-6 inhibitor, intravenous immunoglobulin, and haemoperfusion.
Leelayuwatanakul N, Kongpolprom N, Sriprasart T, Phoophiboon V, Thanthitaweewat V, Thawanaphong S, Sirichana W, Chirakalwasan N, Kawkitinarong K, Sittipunt C, Putcharoen O, Paitoonpong L, Suwanpimolkul G, Jantarabenjakul W, Srisawat N, Pachinburavan M.
Leelayuwatanakul N, et al. Among authors: phoophiboon v.
Respirol Case Rep. 2021 Mar 7;9(4):e0733. doi: 10.1002/rcr2.733. eCollection 2021 Apr.
Respirol Case Rep. 2021.
PMID: 33732466
Free PMC article.